These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11074875)

  • 1. Treatment of atypical depression with cognitive therapy or phenelzine.
    Levitan RD
    Arch Gen Psychiatry; 2000 Nov; 57(11):1084; author reply 1084-5. PubMed ID: 11074875
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
    Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
    Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing depression treatments.
    Rifkin A
    Am J Psychiatry; 2003 Jun; 160(6):1186-7; author reply 1187. PubMed ID: 12777284
    [No Abstract]   [Full Text] [Related]  

  • 4. Medication or psychotherapy for severe depression.
    Reinceke MA; Ewell Foster CJ; Rogers GM; Weill R
    Am J Psychiatry; 2000 Sep; 157(9):1528-9. PubMed ID: 10964885
    [No Abstract]   [Full Text] [Related]  

  • 5. Why the Hamilton Depression Rating Scale endures.
    Licht RW; Bech P
    Am J Psychiatry; 2005 Dec; 162(12):2394-5; author reply 2397-8. PubMed ID: 16330614
    [No Abstract]   [Full Text] [Related]  

  • 6. Reducing relapse in depressed outpatients with atypical features: a pilot study.
    Jarrett RB; Kraft D; Schaffer M; Witt-Browder A; Risser R; Atkins DH; Doyle J
    Psychother Psychosom; 2000; 69(5):232-9. PubMed ID: 10965287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions.
    Casacalenda N; Perry JC; Looper K
    Am J Psychiatry; 2002 Aug; 159(8):1354-60. PubMed ID: 12153828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression.
    Mercier MA; Stewart JW; Quitkin FM
    J Clin Psychiatry; 1992 May; 53(5):166-70. PubMed ID: 1592844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
    Quitkin FM; Stewart JW; McGrath PJ; Liebowitz MR; Harrison WM; Tricamo E; Klein DF; Rabkin JG; Markowitz JS; Wager SG
    Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication treatment versus cognitive behavior therapy.
    Taylor MA
    Am J Psychiatry; 2000 Jun; 157(6):1025-6. PubMed ID: 10831498
    [No Abstract]   [Full Text] [Related]  

  • 11. Cognitive behavioral group therapy and phenelzine both effective in social phobia.
    Thyer BA
    West J Med; 1999 Oct; 171(4):240. PubMed ID: 10578676
    [No Abstract]   [Full Text] [Related]  

  • 12. Can mildly depressed outpatients with atypical depression benefit from antidepressants?
    Stewart JW; McGrath PJ; Quitkin FM
    Am J Psychiatry; 1992 May; 149(5):615-9. PubMed ID: 1575250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How symptomatic do depressed patients remain after benefiting from medication treatment?
    Agosti V; Stewart JW; Quitkin FM; Ocepek-Welikson K
    Compr Psychiatry; 1993; 34(3):182-6. PubMed ID: 8339536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive therapy and pharmacotherapy for depression.
    Hollon SD; Shelton RC; Loosen PT
    J Consult Clin Psychol; 1991 Feb; 59(1):88-99. PubMed ID: 2002147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
    J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequacy of pharmacological treatment.
    Bradwejn J; Meterissian GB
    Am J Psychiatry; 1990 Jul; 147(7):953-4. PubMed ID: 2192565
    [No Abstract]   [Full Text] [Related]  

  • 18. Anxious depression in elderly patients. Response to antidepressant treatment.
    Flint AJ; Rifat SL
    Am J Geriatr Psychiatry; 1997; 5(2):107-15. PubMed ID: 9106374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome.
    Heimberg RG; Liebowitz MR; Hope DA; Schneier FR; Holt CS; Welkowitz LA; Juster HR; Campeas R; Bruch MA; Cloitre M; Fallon B; Klein DF
    Arch Gen Psychiatry; 1998 Dec; 55(12):1133-41. PubMed ID: 9862558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive behavioral treatment of residual symptoms in primary major depressive disorder.
    Fava GA; Grandi S; Zielezny M; Canestrari R; Morphy MA
    Am J Psychiatry; 1994 Sep; 151(9):1295-9. PubMed ID: 8067483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.